ABSTRACT
The left atrial appendage (LAA) has gained increasing attention in the field of cardiology as a potential site for intervention in patients with atrial fibrillation (AF) and an elevated risk of thromboembolic events. Left atrial appendage occlusion (LAAO) has emerged as a promising therapeutic strategy to mitigate the risk of stroke and systemic embolism, especially in individuals who are unsuitable candidates for long-term anticoagulation therapy. This review aims to provide a comprehensive analysis of the current state of LAAO, encompassing its anatomic considerations, procedural techniques, clinical outcomes, and future directions.
Subject(s)
Atrial Appendage , Atrial Fibrillation , Cardiac Catheterization , Stroke , Humans , Atrial Appendage/surgery , Atrial Fibrillation/therapy , Stroke/prevention & control , Stroke/etiology , Cardiac Catheterization/methods , Cardiac Catheterization/trends , Cardiac Surgical Procedures/methods , Septal Occluder Device , Thromboembolism/prevention & control , Thromboembolism/etiology , Left Atrial Appendage ClosureABSTRACT
Atrial fibrillation (AF) is the most common cardiac arrhythmia and its prevalence is continuously increasing in the United States, leading to a progressive rise in the number of disease-related emergency department (ED) visits and hospitalizations. Although optimal long-term outpatient management for AF is well defined, the guidelines for optimal ED management of acute AF episodes is less clear. Studies have demonstrated that discharging patients with AF from the ED after acute stabilization is both safe and cost effective; however, the majority of these patients in the United States and in our institution are admitted to the hospital. To improve care of these patients, we established a multidisciplinary collaboration to develop an evidence-based systematic approach for the treatment and management of AF in the ED, that led to the creation of the University of California-Cardioversion, Anticoagulation, Rate Control, Expedited Follow-up/Education Atrial Fibrillation Pathway. Our pathway focuses on the acute stabilization of AF, adherence to best practices for anticoagulation, and reduction in unnecessary admissions through discharge from the ED with expedited outpatient follow-up whenever safe. A novel aspect of our pathway is that it is primarily driven by the ED physicians, while other published protocols primarily involve consulting cardiologists to guide management in the ED. Our protocol is very pertinent considering the current trend toward increased AF prevalence in the United States, coupled with a need for widespread implementation of strategies aimed at improving management of these patients while safely reducing hospital admissions and the economic burden of AF.
Subject(s)
Atrial Fibrillation , Anticoagulants/therapeutic use , Atrial Fibrillation/epidemiology , Atrial Fibrillation/therapy , Critical Pathways , Emergency Service, Hospital , Hospitalization , Humans , United States/epidemiologyABSTRACT
Cardiac resynchronization therapy (CRT) can improve heart function and decrease arrhythmic events. We tested whether CRT altered circulating markers of calcium handling and sudden death risk. Circulating cardiac sodium channel messenger RNA (mRNA) splicing variants indicate arrhythmic risk, and a reduction in sarco/endoplasmic reticulum calcium adenosine triphosphatase 2a (SERCA2a) is thought to diminish contractility in heart failure. CRT was associated with a decreased proportion of circulating, nonfunctional sodium channels and improved SERCA2a mRNA expression. Patients without CRT did not have improvement in the biomarkers. These changes might explain the lower arrhythmic risk and improved contractility associated with CRT.
Subject(s)
Cardiac Resynchronization Therapy , Biomarkers , Calcium , Death, Sudden , Humans , Sarcoplasmic ReticulumABSTRACT
BACKGROUND: Because of its technical feasibility and presumed safety benefits, balloon cryoablation is being increasingly employed for pulmonary vein (PV) isolation. While acute isolation has been demonstrated in most patients, little data are available on the chronic durability of cryoballoon lesions. METHODS AND RESULTS: Twelve atrial fibrillation patients underwent PV isolation using either a 23-mm or 28-mm cryoballoon. For each vein, after electrical isolation was verified with the use of a circular mapping cathether, 2 bonus balloon ablation lesions were placed. Gaps in balloon occlusion were overcome using either a spot cryocatheter or a "pull-down" technique. A prespecified second procedure was performed at 8-12 weeks to assess for long-term PV isolation. Acute PV isolation was achieved in all PVs in the patient cohort (n = 48 PVs), using the cryoballoon alone in 47/48 PVs (98%); a "pull-down" technique was employed for 5 PVs (1 right superior pulmonary vein, 2 right inferior pulmonary veins, and 2 left inferior pulmonary veins). The gap in the remaining vein was ablated with a spot cryocatheter. During the second mapping procedure, 42 of 48 PVs (88%) remained isolated. One vein had reconnected in 2 patients, while 2 veins had reconnected in another 2 patients. All PVs initially isolated with the "pull-down" technique remained isolated at the second procedure. CONCLUSIONS: Cryoballoon ablation allows for durable PV isolation with the use of a single balloon. With maintained chronic isolation in most PVs, it may represent a significant step toward consistent and lasting ablation procedures.
Subject(s)
Atrial Fibrillation/surgery , Cryosurgery , Pulmonary Veins/surgery , Adult , Atrial Fibrillation/diagnosis , Atrial Fibrillation/physiopathology , Catheterization/instrumentation , Cryosurgery/instrumentation , Czech Republic , Echocardiography, Doppler, Color , Electrocardiography , Female , Humans , Male , Middle Aged , Phlebography , Prospective Studies , Pulmonary Veins/diagnostic imaging , Pulmonary Veins/physiopathology , Recurrence , Time Factors , Treatment OutcomeABSTRACT
The Sprint Fidelis lead has an increased incidence of lead fracture. The manufacturer has recommended programming alerts to preempt lead malfunction due to fracture. The current trigger for an alert is an increase in the right ventricular pacing impedance to greater than 1,000 Omega. Our patient suffered multiple inappropriate implantable cardioverter defibrillator therapies with stable impedance less than 1,000 Omega. This case of lead fracture would not have been detected with these programming alerts. Additional programming measures may detect lead fractures, including changing the lower detection for impedances, arranging for a percentage change in the impedance trend to trigger an alarm, or programming the device to warn if there is an increase in nonphysiologic short R-R interval counts.
Subject(s)
Defibrillators, Implantable , Electrocardiography, Ambulatory/methods , Electrodes, Implanted , Equipment Failure Analysis/methods , Equipment Failure , Aged, 80 and over , Electric Impedance , Humans , MaleSubject(s)
Atrial Flutter/therapy , Body Surface Potential Mapping/methods , Catheter Ablation/methods , Imaging, Three-Dimensional/methods , Situs Inversus/therapy , Atrial Flutter/complications , Atrial Flutter/physiopathology , Computer Systems , Female , Humans , Middle Aged , Situs Inversus/complications , Situs Inversus/physiopathologyABSTRACT
BACKGROUND: Three-dimensional (3D) reconstruction of the left atrium (LA) can be performed using real-time intracardiac echocardiography (ICE) to facilitate image integration during atrial fibrillation (AF) ablation. Current users of this technology generally image the LA indirectly from the right atrium (RA). OBJECTIVE: The purpose of this study was to assess the feasibility and accuracy of image integration with placement of the ICE catheter directly in the LA to visualize the LA. METHODS: Thirty consecutive patients undergoing an AF ablation with the CARTO-Sound system were enrolled. A 10-Fr phased-array ICE catheter was used to obtain two-dimensional echocardiographic images of the LA; in 15 patients the ICE probe was placed in the LA, and in 15 patients it was placed only in the RA. Sequential images were obtained and merged with a preacquired computed tomography/magnetic resonance image. The accuracy of image integration was assessed by the value of the average image integration error after surface registration. RESULTS: Thirty patients (60% paroxysmal AF, LA size = 42 +/- 7 mm, ejection fraction = 62% +/- 10%) were studied. There was no difference in the time required to create the LA anatomic map and perform image integration with imaging from the LA versus the RA (22 +/- 22 vs. 24 +/- 16 minutes; P = .8). The number of ultrasound contours obtained was also similar (LA = 26 +/- 17 vs. RA = 24 +/- 16; P = .7). The average integration error was less with direct LA imaging (LA = 1.83 +/- 0.32 vs. RA = 2.52 +/- 0.58 mm; P = .0004). CONCLUSION: Direct LA imaging with ICE is feasible and results in improved LA visualization and image integration.